Analysis of antibodies from HCV elite neutralizers identifies genetic determinants of broad neutralization
{{output}}
The high genetic diversity of hepatitis C virus (HCV) complicates effective vaccine development. We screened a cohort of 435 HCV-infected individuals and found that 2%-5% demonstrated outstanding HCV-neutralizing activity. From four of these patients, we isola... ...
